Cartesian Therapeutics RNAC
NASDAQ RNAC
$9.27 +0.15 (+1.64%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Sales of Property, Plant and Equipment (2017 - 2020)

Analysis

Cartesian Therapeutics (RNAC) Sales of Property, Plant and Equipment (2017 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Cartesian Therapeutics 271.98 Mn 271.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 24,000.00
Sep 30, 2020 5,000.00
Jun 30, 2020 45,000.00
Dec 31, 2019 28,000.00
Sep 30, 2019 17,000.00
Mar 31, 2019 77,000.00
Dec 31, 2018 -6,000.00
Sep 30, 2018 74,000.00
Jun 30, 2018 31,000.00
Dec 31, 2017 4,000.00